Laxmi Dental Q2FY27: revenue up 10.0% to INR 795.2 mn, EBITDA up 38.5% at 19.2% margin
Q2FY27 revenue up 10.0% to INR 795.2 mn, EBITDA up 38.5% at 19.2% margin, PAT after JV share up 17.6%.
By ScoutQuest · · 2 min read
- Q2FY27 Revenue from Operations
- INR 795.2 mn, up 10.0% YoY
- Q2FY27 EBITDA
- INR 152.7 mn, up 38.5%; margin 19.2% vs 15.3% a year earlier
- Q2FY27 PAT after JV share
- INR 100.4 mn, up 17.6%; 12.6% margin
- Period
- Q2FY27 and H1FY27
- Positioning
- The company calls itself India's only integrated dental products company, the second-largest domestic dental lab and the largest export dental lab, selling into 320+ Indian cities and 95+ export countries.
📉 Q2FY27 revenue from operations rose 10.0% year on year to INR 795.2 mn, with EBITDA up 38.5% to INR 152.7 mn and EBITDA margin at 19.2% against 15.3% a year earlier. PAT after share of JV profit rose 17.6% to INR 100.4 mn, a 12.6% margin, though the presentation notes scanner sales contribution fell to INR 3.5 crore from INR 8.9 crore in the same quarter last year.
🌍 On the segment side the company reports its dental laboratory business up 22.7% year on year on a scanner-excluded basis, with international laboratory revenue up 32.0% to INR 244.0 mn and domestic laboratory up 15.0% to INR 258.3 mn. Aligner solutions grew 21.9% to INR 246.1 mn, led by Illusion Aligners (Bizdent) at 27.7% and Taglus (Vedia) at 19.1%, while Kids-e-Dental, shown at 100% and not consolidated, rose 16.7% to INR 62.6 mn.
📉 For the full FY26, revenue from operations was INR 2,778.6 mn against INR 2,391.1 mn in FY25, but EBITDA margin slipped to 15.6% from 17.5% and PAT after share of JV profit declined to INR 289.2 mn from INR 318.3 mn. The FY26 profit line carries a negative exceptional item of 57.8 (INR mn) versus a positive 70.3 (INR mn) in FY25, so the swing is not operating growth alone.
🏭 The presentation states that INR 48.1 crore of unutilised IPO proceeds will be redeployed, including INR 26.9 crore for land and building for a company-owned dental lab and aligner plant, with 64% of INR 128.2 crore net IPO proceeds deployed as of 30 Sep 2026. Management also says it plans to deploy scanners on a subscription model to cut upfront adoption costs, and lists a target of 90%+ domestic lab digital penetration from about 75% in FY26.
Also from Laxmi Dental
Laxmi Dental Q2 FY27 adjusted EBITDA INR 160.1 mn, up 17.1% YoY; gross margin 76.9%
3 Nov 2026
Board approves unaudited Q2 and H1 FY27 results; auditor review conclusion unmodified
3 Nov 2026
Laxmi Dental schedules Q2FY27 and H1FY27 earnings conference call for November 4, 2026
28 Oct 2026
More numbers
- Revenue from operations, Q2FY27795.2 (INR mn)
- EBITDA, Q2FY27152.7 (INR mn)
- PAT after share of profit/loss from JVs, Q2FY27100.4 (INR mn)
- EBITDA margin, Q2FY2719.2%
- PAT margin (after share of JVs), Q2FY2712.6%
- Revenue from operations, FY262,778.6 (INR mn)
- PAT after share of profit/loss from JVs, FY26289.2 (INR mn)
- EBITDA margin, FY2615.6%
- Unutilised IPO proceeds to be redeployed₹48.1 Cr
- Net IPO proceeds deployed64%
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.